Pending Projects


A Randomized, Double-blind Trial of Oral Fecal Microbiota Transplantation versus Placebo for the Eradication of Vancomycin-resistant Enterococci Colonization from the Gut (VRE-FMT)

The VRE-FMT trial (pending NIH U01) will test a novel intervention, fecal microbiota transplant (FMT) in oral encapsulation, for eradication of vacomycin-resistant enterococci (VRE) colonization in asymptomatic VRE gut colonized patients in a randomized, double-blind, placebo-controlled trial.

Principal Investigator DCC: Nasia Safdar, MD, University of Wisconsin-Madison
Co-Investigator, DCC Director: KyungMann Kim, PhD, University of Wisconsin-Madison
Target Enrollment: 90

The VRE-FMT Data Coordinating Center (DCC) will be led by Professor Kim. He will provide expertise and support for the VRE-FMT trial with limited involvement in data management which will be done using REDCap.

Contact Us

KyungMann Kim, PhD
DCC Principal Investigator
kyungmann.kim@wisc.edu
608-265-6380

Kelly Miller, BS, CCRC
DCC Research Administrator
kamiller@biostat.wisc.edu
608-262-8141